{"id":"W2962953235","doi":"10.1016/j.ejim.2019.07.009","title":"North America anticoagulation forum guidance on reversal of direct oral anticoagulants","year":2019,"lang":"en","type":"editorial","venue":"European Journal of Internal Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Rivaroxaban; Dabigatran; Apixaban; Edoxaban; Idarucizumab; Prothrombin complex concentrate; Intensive care medicine; Warfarin; Pharmacology; Internal medicine; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001289181,0.0004107532,0.001947821,0.0006884161,0.000034665,0.00001744337,0.0004382176,0.0001058935,0.0002159126],"category_scores_gemma":[0.004474943,0.0002787376,0.0004571367,0.0002791004,0.0001813404,0.0001311408,0.000108727,0.0008679774,0.0001048282],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001260813,"about_ca_system_score_gemma":0.0001401626,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003380995,"about_ca_topic_score_gemma":0.000003973389,"domain_scores_codex":[0.995243,0.0004333464,0.001883254,0.0002976524,0.001856609,0.0002861827],"domain_scores_gemma":[0.9946396,0.0008019923,0.003033625,0.0004232562,0.0009040943,0.0001973702],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003302784,0.00003164859,0.04070691,0.0003188679,0.0007586612,0.0006180505,0.0001700864,0.00009396011,0.0003423491,0.000005271405,0.945391,0.008260406],"study_design_scores_gemma":[0.005467996,0.006975593,0.04249195,0.007174193,0.0009645621,0.00004142251,0.0001056008,0.00008796671,0.0001055367,0.000004054729,0.9363414,0.000239725],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.0287768,0.001379341,0.002084699,0.003390557,0.9361646,0.0006076196,0.0000710489,0.00004488634,0.02748048],"genre_scores_gemma":[0.2719732,0.000931331,0.0006352243,0.0004947606,0.7182036,1.412531e-7,0.0001303092,0.000129086,0.007502349],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.2431964,"threshold_uncertainty_score":0.9999665,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03750406740671614,"score_gpt":0.3299992287163629,"score_spread":0.2924951613096468,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}